You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DAY101

Showing 26 - 50 of 7,582
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Eye Diseases, Presbyopia, Refractive Errors Trial in Newport Beach (Aceclidine + Brimonidine, Aceclidine)

Recruiting
  • Eye Diseases
  • +5 more
  • Newport Beach, California
    Site #101
Jul 7, 2023

Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Oct 5, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

Recruiting
  • Solid Tumor, Adult
  • +19 more
  • Irving, Texas
  • +2 more
May 24, 2023

Celiac Disease, Coeliac Disease Trial (KAN-101, Placebo)

Not yet recruiting
  • Celiac Disease
  • Coeliac Disease
  • (no location specified)
Aug 14, 2023

Advanced Solid Tumors Trial in Wuhan (HV-101)

Recruiting
  • Advanced Solid Tumors
  • HV-101
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
May 11, 2023

Breast Cancer, Radiation Dermatitis Trial (FR-101 Chest Dressing)

Not yet recruiting
  • Breast Cancer
  • Radiation Dermatitis
  • FR-101 Chest Dressing
  • (no location specified)
Sep 15, 2023

Beta-Thalassemia Trial (CS-101 injection)

Not yet recruiting
  • Beta-Thalassemia
  • CS-101 injection
  • (no location specified)
Sep 27, 2023

Beta-Thalassemia Trial in Nanning (CS-101)

Recruiting
  • Beta-Thalassemia
  • CS-101
  • Nanning, China
    The First Affiliated Hospital of Guangxi Medical University
Sep 9, 2023

Advanced Solid Tumor Trial in San Antonio (LB101)

Recruiting
  • Advanced Solid Tumor
  • San Antonio, Texas
    NEXT Oncology
Apr 6, 2023

Amyotrophic Lateral Sclerosis Trial (89Zr-DFO-AP-101)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Jul 26, 2023

Advanced Solid Tumor Trial in Hangzhou (BR101)

Recruiting
  • Advanced Solid Tumor
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University Medical Co
Aug 14, 2023

COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
  • Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
  • (no location specified)
Jun 19, 2023

Urinary Tract Infections, Pyelonephritis Trial (NRX101 (a fixed dose combination of D-cycloserine (DCS) and lurasidone HCl

Not yet recruiting
  • Urinary Tract Infections
  • Pyelonephritis
  • NRX101 (a fixed dose combination of D-cycloserine (DCS) and lurasidone HCl (lurasidone))
  • (no location specified)
Nov 7, 2023

Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma Trial (AFM13, AB-101, Cyclophosphamide)

Not yet recruiting
  • Relapsed or Refractory Hodgkin Lymphoma
  • Peripheral T Cell Lymphoma
  • (no location specified)
May 30, 2023

Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +4 more
  • GC101 TIL
  • Beijing, China
    Beijing Cancer Hospital
Nov 7, 2023

QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)

Recruiting
  • QT/QTc
  • Ecopipam Hydrochloride
  • +2 more
  • Austin, Texas
    PPD Austin Phase 1 Clinical Research Unit
Apr 21, 2023

Idiopathic Pulmonary Fibrosis Trial in Adelaide (taladegib, nintedanib)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Adelaide, South Australia, Australia
    Research Site
Apr 5, 2023

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Carcinoma of Vagina Trial in Shanghai (HRYZ-T101 Injection, Fludarabine

Not yet recruiting
  • Cervical Cancer
  • +5 more
  • HRYZ-T101 Injection
  • Fludarabine + Cyclophosphamide
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 17, 2023

Vaginal Flora Imbalance Trial in Cork (FB101)

Recruiting
  • Vaginal Flora Imbalance
  • FB101
  • Cork, Ireland
    Atlantia Clinical Trials
May 10, 2023

Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • (no location specified)
Oct 13, 2023

Parkinson Disease Trial in Nottingham (NM-101, Placebo)

Not yet recruiting
  • Parkinson Disease
  • Nottingham, United Kingdom
    Quotient Sciences
Mar 16, 2023

Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC), Systemic Sclerosis (SSc) Trial in Tel Aviv (CM-101,

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • +2 more
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Sep 7, 2023

Community-acquired Pneumonia, Bacterial Pneumonia Trial in Cincinnati (CMTX-101, Placebo)

Recruiting
  • Community-acquired Pneumonia
  • Bacterial Pneumonia
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Jan 20, 2023

Parkinson's Disease Trial in Secaucus (MT101-5)

Completed
  • Parkinson's Disease
  • Secaucus, New Jersey
    Frontage Clinical Services, 1nc.
Apr 25, 2023

HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)

Not yet recruiting
  • HCC
  • Zabadinostat (CXD101) and Geptanolimab
  • Lenvatinib and Sorafenib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
May 15, 2023